IRIS
SCARPELLI, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.195
EU - Europa 10.386
AS - Asia 9.390
SA - Sud America 2.219
AF - Africa 515
Continente sconosciuto - Info sul continente non disponibili 431
OC - Oceania 6
Totale 46.142
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.787
SG - Singapore 3.162
RU - Federazione Russa 2.429
VN - Vietnam 1.841
BR - Brasile 1.754
UA - Ucraina 1.574
CN - Cina 1.289
IT - Italia 1.244
IE - Irlanda 999
HK - Hong Kong 941
DE - Germania 906
SE - Svezia 870
TR - Turchia 813
FR - Francia 615
DK - Danimarca 576
FI - Finlandia 409
GB - Regno Unito 391
KR - Corea 326
IN - India 248
CI - Costa d'Avorio 229
CA - Canada 193
BD - Bangladesh 178
AR - Argentina 156
MX - Messico 131
NL - Olanda 88
EC - Ecuador 84
ID - Indonesia 81
ZA - Sudafrica 80
IQ - Iraq 78
MA - Marocco 68
CO - Colombia 67
JP - Giappone 62
PL - Polonia 58
PK - Pakistan 51
VE - Venezuela 49
ES - Italia 47
UZ - Uzbekistan 42
PH - Filippine 40
BE - Belgio 38
SA - Arabia Saudita 30
CL - Cile 29
TN - Tunisia 28
PY - Paraguay 27
EG - Egitto 24
DZ - Algeria 22
AE - Emirati Arabi Uniti 21
AT - Austria 20
MY - Malesia 20
PE - Perù 20
TH - Thailandia 20
EE - Estonia 18
JO - Giordania 18
RO - Romania 18
EU - Europa 17
KE - Kenya 16
BO - Bolivia 15
KZ - Kazakistan 15
UY - Uruguay 15
CR - Costa Rica 14
ET - Etiopia 13
TW - Taiwan 13
HN - Honduras 12
JM - Giamaica 12
AZ - Azerbaigian 11
BH - Bahrain 11
CZ - Repubblica Ceca 11
NP - Nepal 11
OM - Oman 10
IL - Israele 9
LB - Libano 9
PT - Portogallo 9
BG - Bulgaria 8
AL - Albania 7
AO - Angola 7
GR - Grecia 7
KG - Kirghizistan 7
LT - Lituania 7
TT - Trinidad e Tobago 7
AU - Australia 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
NG - Nigeria 5
PA - Panama 5
AM - Armenia 4
BB - Barbados 4
BY - Bielorussia 4
IR - Iran 4
NI - Nicaragua 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SN - Senegal 4
SV - El Salvador 4
GE - Georgia 3
GT - Guatemala 3
MD - Moldavia 3
ML - Mali 3
MU - Mauritius 3
RS - Serbia 3
Totale 45.673
Salva come PNG Salva come JPEG
Città #
Ashburn 3.396
Singapore 2.048
Chandler 1.751
Jacksonville 1.637
Fairfield 1.437
Des Moines 1.204
Dallas 1.138
Dublin 997
Boardman 933
Hong Kong 905
Wilmington 818
San Jose 801
Council Bluffs 709
Woodbridge 644
Ho Chi Minh City 605
Seattle 584
Houston 574
New York 561
Cambridge 426
The Dalles 415
Hanoi 410
Princeton 404
Lawrence 402
San Mateo 390
Lauterbourg 360
Beijing 331
Milan 299
Ann Arbor 290
Moscow 266
Los Angeles 248
Abidjan 229
Centro 213
San Diego 179
Hefei 178
São Paulo 152
Munich 116
Santa Clara 115
Chicago 110
London 99
Haiphong 95
Da Nang 92
Pune 78
Buffalo 74
Helsinki 74
Orem 74
Shanghai 66
Mexico City 64
Washington 63
Miano 62
Turku 53
Tokyo 52
Rio de Janeiro 50
Columbus 49
Warsaw 48
Montreal 47
Redmond 47
Vancouver 46
Brooklyn 45
Frankfurt am Main 45
Guangzhou 45
Norwalk 44
Atlanta 43
Turin 43
Tashkent 40
Izmir 39
Phoenix 39
Salt Lake City 39
Wuhan 39
Baghdad 38
Curitiba 38
Johannesburg 37
Denver 36
Brussels 34
Guayaquil 34
Amsterdam 33
Chennai 33
Manchester 33
Porto Alegre 31
Rome 31
Ancona 30
Falls Church 29
San Francisco 29
Elk Grove Village 28
Belo Horizonte 27
Biên Hòa 26
Hải Dương 26
Brasília 25
Stockholm 25
Can Tho 24
Dhaka 24
Jiaxing 23
Thái Nguyên 23
Campinas 22
Poplar 21
Quito 21
New Delhi 20
Quận Ba 20
Thái Bình 20
Istanbul 19
Marche 19
Totale 28.848
Salva come PNG Salva come JPEG
Nome #
Role of electron microscopy in the diagnosis of CADASIL syndrome: a study of 32 patients 771
Urethral caruncle: clinicopathologic features of 41 cases 281
Metabolic phenotype of bladder cancer 267
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 223
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 218
Immunotherapy in genitourinary cancers: Where are we going? 211
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 207
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 202
Are liver nested stromal epithelial tumors always low aggressive? 202
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 198
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 196
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 195
2004 WHO classification of the renal tumors of the adults. 194
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 194
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 193
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 187
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 186
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 179
A rare case of chordoma and craniopharyngioma treated by an endoscopic endonasal, transtubercular transclival approach. 177
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 176
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 175
Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807 174
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 171
Standardized mitotic counts in breast cancer evaluation of the method 171
Secondary neoplasms of the urinary system and male genital organs. 169
HER family receptor expression and prognosis in pancreatic cancer 169
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 169
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 168
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 165
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 165
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 164
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 163
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 163
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 163
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 162
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 162
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 161
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 161
Endoscopy-verified occult subependymal dissemination of glioblastoma and brain metastasis undetected by MRI: prognostic significance. 160
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 159
Microbiome and cancers, with focus on genitourinary tumors 158
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 158
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 156
Seminoma Retroperitoneal Relapse 23 Years After Surgery 156
Metabolic Alterations in Renal and Prostate Cancer 155
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 153
Active surveillance for low-risk prostate cancer. 152
Meningioma-like cerebral relapse of Hodgkin's disease. 152
Subarachnoid haemorrhage due to widely metastatising malignant ependymoma. 149
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 149
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions 149
Bone targeting agents in patients with metastatic prostate cancer: State of the art 148
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 148
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 147
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 147
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 147
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 146
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 146
Is There a Role for Immunotherapy in Prostate Cancer? 145
2009 update on the classification of renal epithelial tumors in adults 143
Genitourinary cancers: molecular determinants for personalized therapies 143
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 143
Epileptogenic Low-Grade Tumours in Childhood: Outcome after Lesionectomy 142
A low grade PIN-like neoplasm of the transition zone immunohistochemically negative for basal cell markers: a possible example of low grade adenocarcinoma with stratified epithelium. 142
[Magnetic resonance in the pathologic evaluation of the isolated human brain]. 142
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 142
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 142
Angioblastic parasellar extradural tumours. 141
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 141
Rare synchronous association of vestibular schwannoma and indolent insular oligodendroglioma in a patient without neurofibromatosis: controversial issue of timing for surgical treatment of asymptomatic low-grade gliomas. 141
Pd-l1 inhibitors for the treatment of prostate cancer 141
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. 140
Prostatic Intraepithelial Neoplasia (pin) - Performance of Bayesian Belief Network For Diagnosis and Grading. 139
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 139
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 139
Seminal Vesicle Intraepithelial Neoplasia Versus Basal Cell Hyperplasia in a Seminal Vesicle. 138
Occurrence of Cell-death (apoptosis) In Prostatic Intraepithelial Neoplasia 138
An overview of emerging immunotargets of genitourinary tumors 138
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers 138
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 137
Mitochondrial encephalomyopathy lactic acidosis and strokelike episodes mimicking occipital idiopathic epilepsy. 137
A contemporary update on pathology reporting for urinary bladder cancer. 137
SURGICAL TREATMENT FOR GLIOBLASTOMA MULTIFORME: OUTCOME AND ANALYSIS OF PROGNOSTIC FACTORS ESPECIALLY ORIENTED TO THE EXTENT OF SURGICAL RESECTION 137
Morphological diagnosis of urothelial neoplasms. 136
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 136
Bladder cancer: molecular determinants of personalized therapy 136
Present and future of personalized medicine in adult genitourinary tumors 135
Epigenetic modifications and modulators in prostate cancer 135
Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma 134
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 133
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 133
The identification of immunological biomarkers in kidney cancers 133
"No pay, no play" or from "defensive or passive pathology" to "active, clinically oriented pathology" 132
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 132
RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications 131
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 131
Computer assisted discrimination of glioblastomas 131
Quantitative-analysis of Prostatic Intraepithelial Neoplasia On Tissue-sections. 130
[Intracranial pressure in traumatic brain laceration and intracerebral hematomas (author's transl)]. 130
Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives. 130
Totale 16.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 220.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.681
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.714 0 620 95 136 28 269 82 202 192 273 190 627
2022/20235.798 523 459 326 462 379 1.580 3 350 1.303 34 267 112
2023/20243.068 555 78 200 429 510 696 53 75 6 53 26 387
2024/20256.021 657 522 240 141 214 222 560 262 1.535 462 505 701
2025/202615.919 787 1.103 1.098 1.586 1.508 1.030 2.752 1.669 2.067 1.256 285 778
2026/20271.321 623 698 0 0 0 0 0 0 0 0 0 0
Totale 46.142